MedPath
NMPA Approval

Mifepristone Tablets

国药准字H20033551

June 7, 2024

Drug Information

米非司酮片

夕韵

片剂

25mg

化学药品

June 7, 2024

Company Information

Applicant Company

武汉东湖新技术开发区光谷七路77号

Manufacturing Company

武汉东湖新技术开发区光谷七路77号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米非司酮片 - NMPA 批准文号 | MedPath